Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. May 28, 2014; 20(20): 6262-6278
Published online May 28, 2014. doi: 10.3748/wjg.v20.i20.6262
Published online May 28, 2014. doi: 10.3748/wjg.v20.i20.6262
Combination therapy | Monotherapy | HBeAg seroconversion | HBV DNA | HBsAg clearance | Histological improvement | Drug resistance |
LAM + ADV | LAM | = | = | N/A | = | ↓ |
LAM + ADV | ETV | N/A | = | N/A | N/A | N/A |
ETV + TDF | ETV | = | = | N/A | = | = |
LAM + PEG-IFN | LAM | ↑ | ↓ | ↑ | ↑ | ↓ |
ADV + PEG-IFN | PEG-IFN | N/A | ↓ | ↑ | N/A | N/A |
ETV + PEG-IFN | ETV | ↑ | ↓ | ↑ | N/A | N/A |
- Citation: Tang CM, Yau TO, Yu J. Management of chronic hepatitis B infection: Current treatment guidelines, challenges, and new developments. World J Gastroenterol 2014; 20(20): 6262-6278
- URL: https://www.wjgnet.com/1007-9327/full/v20/i20/6262.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i20.6262